866-997-4948(US-Canada Toll Free)

Heart Failure Congress 2011 - Post - Conference Review and Analysis

Published By :

GlobalData

Published Date : May 2011

Category :

Therapeutic Area

No. of Pages : 12 Pages


GlobalData, the industry analysis specialist, has released its new conference alerts, Heart Failure Congress 2011 - Post - Conference Review and Analysis. The conference alert is an essential source of information and analysis on the emerging therapies and new disease management techniques.

Scope

The report provides complete coverage of conference. Its scope includes -
  • Qualitative analysis of the studies and clinical trials presented at the conference and their impact on the key market dynamics and future treatment paradigm.
  • review of pre- and post-conference KOL/analyst comments
  • Market revenue data for 2010 and forecast forward to 2017 for a specific disease area (if the conference being covered is focused on a specific disease area).
  • Review of key industry trends and events which are likely to impact and change the dynamics of the concerned disease markets in the long run.
Reasons to buy

The report will serve to facilitate your decision making in the concerned therapy areas. It will allow you to -
  • Develop business strategies by understanding the trends and developments that are driving or are expected to drive the market in the concerned disease areas.
  • Explore M&A opportunities by identifying key products and market players.
  • Develop market-entry and market expansion strategies.
  • Identify key players best positioned to take advantage of the market opportunities.
  • Make more informed business decisions from the insightful and in-depth analysis of the market and the factors influencing the same.
Table of Content:

1 Table of contents

1 Table of contents 2

2 Heart Failure Congress 2011: Post-Conference Highlights 3
2.1 Istaroxime Mechanism of Action in Heart Failure 3
2.2 Plasma Renin Activity and Angiotensinogen M235T Polymorphism Are Determinants of Aldosterone Escape in Patients with Systolic Heart Failure 4
2.3 Metformin Protects Cardiomyocyte Against Doxorubicin-Induced Stress  Oxidative Via Adiponectin Receptors 5
2.4 Socs1 Gene Transfer Accelerates the Transition to Heart Failure through the Inhibition of the Gp130/Jak/Stat Pathway in a Chronic Pressure-Overload Rat  Model 6
2.5 Choosing Beta-Blockers in Treating Patients with Chronic Heart Failure      in Combination with Chronic Obstructive Pulmonary Disease 7
2.6 Metformin Protects Cardiomyocyte against Doxorubicin-Induced Stress  Oxidative Via Adiponectin Receptors 8
2.7 Genetics of Dilated Cardiomyopathy Novel Mutations in the RNA-Binding  Motif Protein 20 Gene (Rbm20) 9
2.8 Genetic Variants Associated to Reverse Remodelling After Cardiac Resynchronization Therapy 10
2.9 Abbreviations 11
2.10 Disclaimer 12

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *